-
Mar 26, 2026, 7:00 am133 ptsUntil recently, a patient could not receive an Alzheimer’s diagnosis without an expensive scan or invasive procedure. Last year, the Food and Drug Administration (FDA) cleared two blood-based biomarker tests—or BBB—that require only a routine blood sample for use in diagnosing Alzheimer’s…
The ‘Doom’ Computer Game Was Part Of Trump’s Wild And Baseless ‘Election Security Nightmare’ Talking Points Memo 120
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.